NCT04277182

Brief Summary

This experimental study will be carried out at Ege University Laboratory Animals Application and Research Center to identify the efficacy of 10% propolis and 15% propolis on wound healing in a second-degree superficial burn wound. In the study, 36 adult (8-12 week old) Wistar-Albino rats with a weight of 200-300 grams will be used in each group. Each group will include 6 rats. Stratified randomization will be used to randomize rats according to their gender and weight. After randomization, a burnt area will be created on the back of the rats and dressings will be made every day. Following the creation of the burn, biopsy samples will be taken on the 3rd, 7th, 14th and 21st days and at the light microscopic level; bulla, erythema, oedema, burn depth, inflammatory cell infiltration, necrosis, ulceration, angiogenesis, neovascularization, fibroblast proliferation, collagenization, epithelization, fibrosis, the number of hair follicles and damage to the skin attachments. In the immunohistochemical examination of biopsy samples, samples will be taken for the evaluation of superoxide dismutase, malondialdehyde, myeloperoxidase in the evaluation of the tumour necrosis factor-alpha, interleukin-1β and oxidative stress in the EBB period in order to evaluate the acute phase reactants. Fungal and gram staining will be done in order to determine the pathogen reproduction in biopsy samples taken on the 3rd and 7th day. Masson trichrome in order to detect fibrosis in biopsy samples taken on the 14th and 21st day; Hydroxyproline examination will be examined in order to evaluate collagen formation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 20, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 28, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 28, 2020

Completed
Last Updated

August 3, 2022

Status Verified

August 1, 2022

Enrollment Period

27 days

First QC Date

February 17, 2020

Last Update Submit

August 2, 2022

Conditions

Keywords

BurnBurn woundPropolisWound healing

Outcome Measures

Primary Outcomes (41)

  • wound size

    photos will be taken every day to determine the wound size

    21 days

  • bulla

    examination of the skin at the light microscopic level. Bulla will be considered as present or absent.

    3rd day of the research

  • bulla

    examination of the skin at the light microscopic level. Bulla will be considered as present or absent.

    7th day of the research

  • bulla

    examination of the skin at the light microscopic level. Bulla will be considered as present or absent.

    14th day of the research

  • bulla

    examination of the skin at the light microscopic level. Erythemawill be considered as present or absent.

    21st day day of the research

  • edema

    examination of the skin at the light microscopic level. Edema will be considered as present or absent.

    3rd day of the research

  • edema

    examination of the skin at the light microscopic level. Edema will be considered as present or absent.

    7th day of the research

  • edema

    examination of the skin at the light microscopic level. Edema will be considered as present or absent.

    14th day of the research

  • edema

    examination of the skin at the light microscopic level. Edema will be considered as present or absent.

    21st day of the research

  • inflammatory cell infiltration

    examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.

    3rd day of the research

  • inflammatory cell infiltration

    examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.

    7th day of the research

  • inflammatory cell infiltration

    examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.

    14th day of the research

  • inflammatory cell infiltration

    examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.

    21st day of the research

  • necrosis

    examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.

    3rd day of the research

  • necrosis

    examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.

    7th day of the research

  • necrosis

    examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.

    14th day of the research

  • necrosis

    examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.

    21st day of the research

  • ulceration

    examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.

    3rd day of the research

  • ulceration

    examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.

    7th day of the research

  • ulceration

    examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.

    14th day of the research

  • ulceration

    examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.

    21st day of the research

  • angiogenesis

    examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.

    3rd day of the research

  • angiogenesis

    examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.

    7th day of the research

  • angiogenesis

    examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.

    14th day of the research

  • angiogenesis

    examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.

    21st day of the research

  • fibroblast proliferation

    examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.

    3rd day of the research

  • fibroblast proliferation

    examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.

    7th day of the research

  • fibroblast proliferation

    examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.

    14th day of the research

  • fibroblast proliferation

    examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.

    21st day of the research

  • epithelization

    examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.

    3rd day of the research

  • epithelization

    examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.

    7th day of the research

  • epithelization

    examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.

    14th day of the research

  • epithelization

    examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.

    21st day of the research

  • collagenization

    examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.

    3rd day of the research

  • collagenization

    examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.

    7th day of the research

  • collagenization

    examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.

    14th day of the research

  • collagenization

    examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.

    21st day of the research

  • microorganism colonization

    examination of the skin at the light microscopic level. Colonization will be considered as present or absent.

    3rd day of the research

  • microorganism colonization

    examination of the skin at the light microscopic level. Colonization will be considered as present or absent.

    7th day of the research

  • microorganism colonization

    examination of the skin at the light microscopic level. Colonization will be considered as present or absent.

    14th day of the research

  • microorganism colonization

    examination of the skin at the light microscopic level. Colonization will be considered as present or absent.

    21st day of the research

Study Arms (6)

Control group

PLACEBO COMPARATOR

It will be accepted as the control group and 4 experimental burn wounds will be created on the back of the rats in the group and no treatment will be given.

Biological: burn wound dressing

1% Silver Sulfadiazine

ACTIVE COMPARATOR

4 experimental burn wounds will be created on the back of the rats in the group and dressing with 1% Silver Sulfadiazine will be done on the back of the rats every day for 21 days.

Biological: burn wound dressing

%0.2 Nitrafurozon

ACTIVE COMPARATOR

4 experimental burn wounds will be created on the back of the rats in the group and dressing with %0.2 Nitrafurozon will be done on the back of the rats every day for 21 days.

Biological: burn wound dressing

10% Propolis

EXPERIMENTAL

4 experimental burn wounds will be created on the back of the rats in the group and dressing with 10% Propolis will be done on the back of the rats every day for 21 days.

Biological: burn wound dressing

15% Propolis

EXPERIMENTAL

4 experimental burn wounds will be created on the back of the rats in the group and dressing with 15% Propolis will be done on the back of the rats every day for 21 days.

Biological: burn wound dressing

Propolis vehicle

ACTIVE COMPARATOR

4 experimental burn wounds will be created on the back of the rats in the group and dressing with Propolis vehicle will be done on the back of the rats every day for 21 days.

Biological: burn wound dressing

Interventions

1. st. group: It will be considered as a control group and rats will not be treated. 2. nd. group: Vehicle group, Propolis vehicle will be applied topically to rats for 21 days. 3. rd group: Silver Sulfadiazine group, 1% Silver Sulfadiazine will be applied topically to rats for 21 days. 4. th. group: Nitrafurozon group, 0.2% Nitrafurozon will be applied topically for 21 days. 5. th. group: 10% Propolis group, 10% Propolis will be applied topically for 21 days. 6. th. group: 15% Propolis group, 15% Propolis will be applied topically for 21 days.

%0.2 Nitrafurozon1% Silver Sulfadiazine10% Propolis15% PropolisControl groupPropolis vehicle

Eligibility Criteria

Age8 Weeks - 12 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • adult (8-12 weeks)
  • grams
  • Wistar-Albino rat
  • with 4 second-degree superficial contact burn are at its back.

You may not qualify if:

  • the death of the rat in the research process

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University

Izmir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Burns

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Figen Yardımcı

    Ege University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
the researcher who will analyze the primary outcome of the study will not know which group of animals the samples were taken from.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: * 1st. group: It will be considered as a control group and rats will not be treated. * 2nd. group: Vehicle group, Propolis vehicle will be applied to rats for 21 days. * 3rd. group: Silver Sulfadiazine group, 1% Silver Sulfadiazine will be applied topically to rats for 21 days. * 4th. group: Nitrafurozon group, 0.2% Nitrafurozon will be applied topically for 21 days. * 5th. group: 10% Propolis group, 10% Propolis will be applied topically for 21 days. * 6th. group: 15% Propolis group, 15% Propolis will be applied topically for 21 days.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

February 17, 2020

First Posted

February 20, 2020

Study Start

September 1, 2020

Primary Completion

September 28, 2020

Study Completion

September 28, 2020

Last Updated

August 3, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

the study's data is planned to be published and shared in a scientific paper

Locations